Skip to content

Nutrition Intervention of Complementary Milk Feeding to Improve Linear Growth of at Risk and Stunted Children

Nutrition Intervention of Complementary Milk Feeding to Improve Linear Growth of at Risk and Stunted Children Aged Between 12-36 Months

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05670002
Enrollment
118
Registered
2023-01-03
Start date
2022-11-30
Completion date
2024-03-25
Last updated
2025-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

At Risk or Stunted Children

Brief summary

This is a non-randomized open label 6 months intervention study that aims to assess the effectiveness of consuming milk daily for 6 months will improve the linear growth rate of children aged 12-36 months.

Interventions

DIETARY_SUPPLEMENTMilk supplement

Children will take the milk supplement for a period of 6 months. During the intervention, anthropometry data, Zinc Protoporphyrin levels, dietary intake, any illness will be recorded.

Sponsors

Universiti Sains Malaysia
CollaboratorOTHER
FrieslandCampina
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Months to 36 Months
Healthy volunteers
Yes

Inclusion criteria

1. Malaysian child 2. Boys and girls between the age of 12 and 36 months 3. Length-for-age z score (LAZ) \<-1.5 SD and \> -3 SD according to the WHO Growth standard 4. Weight-for-age z score WAZ \<1.0 SD and \> -3 SD 5. Parents and/or legal guardian who can speak and read Malay or English language 6. Written informed consent from parents and/or legal guardian 7. Child who are apparently healthy with no obvious on-going infection and no history of chronic illness. 8. Child with no physical and/or mental illness 9. Parents and/or legal guardian who owns a mobile phone or smart phone 10. Mothers who have ever received breastfeeding counselling from a qualified breastfeeding counsellor.

Exclusion criteria

1. Child with zinc protoporphyrin (ZnPP) value of \>65 (at either -T3 or T0) 2. Clinical symptoms of iron deficiency as examined by Doctor even with zinc protoporphyrin (ZnPP) value between 40-64 3. Child with severe acute malnutrition, other chronic diseases or any congenital disorder or deformity 4. Child with an ongoing episode of diarrhoea or a history of persistent diarrhoea in the past month 5. Child with history of cow's milk allergy/intolerance to milk 6. Child who is already taking multivitamins, including iron, before enrolled to the study 7. Child who is taking breastmilk as part of the diet

Design outcomes

Primary

MeasureTime frameDescription
Linear growth6 monthsChange in LAZ/HAZ z-score from baseline to after 6 months of intervention

Secondary

MeasureTime frameDescription
Growth velocity9 monthsCompare growth velocity between 3 months pre- to first 3 months and 6 months post intervention
Zinc Protoporphyrin (ZnPP) levels9 monthsAny change in ZnPP levels pre and post intervention

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026